Market Place
Sourcing Support
Beacon Announces Data from Ph 2 Trial in X-Linked Retinitis
15 Oct 2024 //
PR NEWSWIRE
Beacon Presents 36-Month Results Phase I/2 For XLRP
19 Sep 2024 //
PR NEWSWIRE
Beacon Biosignals Partners With Skye Bioscience On Sleep Endpoints
24 Jul 2024 //
GLOBENEWSWIRE
Beacon attracts $170M to push eye disease gene therapy through late-stage trial
03 Jul 2024 //
FIERCE BIOTECH
Beacon Therapeutics treats first patient with AGTC-501 in pivotal VISTA trial
17 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
eyeDNA plans pivotal trial of retinitis pigmentosa therapy
06 May 2024 //
PHARMAPHORUM
Ascend Advanced Therapies Acquires CMC Team from Beacon Therapeutics
09 Apr 2024 //
BIOSPECTRUMASIA
Ascend Acquires Florida Facility and Expertise, Bolstering Gene Therapy DevP
09 Apr 2024 //
PR NEWSWIRE
Beacon launches with £96 million to develop a new generation of gene therapies
12 Jun 2023 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.